FEATURED NEWS

• HDA Statement on Senate Confirmation of Dr. Robert Califf as FDA Commissioner

  February 16, 2022

  Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement upon the U.S. Senate’s vote to confirm Dr. Robert Califf as FDA Commissioner.

• HDA Statement on Maryland Legislation Designed to Clarify Role of Critical Pharmacy Partners

  February 11, 2022

  The Healthcare Distribution Alliance (HDA) issued the following statement today from HDA Senior Vice President of State Government Affairs and Alliance Development Matt DiLoreto, upon introduction of SB 823 and HB 973 by the Maryland Legislature.

• Cowman and O’Dowd To Lead HDA Research Foundation Board of Directors

  February 9, 2022

  The HDA Research Foundation announced Craig Cowman of Cardinal Health as Chairman of its Board of Directors. Stephen O’Dowd of Eisai, Inc., is Vice Chairman.

• HDA Statement on FDA Distributor Licensure Proposed Rule

  February 4, 2022

  The Healthcare Distribution Alliance (HDA) released the following statement from President and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers.”

• HDA Research Foundation Announces Annual Supply Chain Scholars

  January 24, 2022

  The HDA Research Foundation today announces it has awarded graduate-level scholarships to four pharmaceutical supply chain leaders. The program was recently renamed to honor Karen J. Ribler, the Foundation’s former COO who led the organization for nearly 10 years; Ms. Ribler passed away in June 2021.